Last updated: July 17, 2026

Application No. 18/553,233

METHOD OF PRODUCING REGULATORY T CELLS BY CULTURING REGULATORY T CELLS OBTAINED FROM UMBILICAL CORD BLOOD

Non-Final OA

Filed

Sep 29, 2023

Priority

Apr 02, 2021 — provisional 63/170,214 +1 more

Examiner

SZPERKA, MICHAEL EDWARD

Art Unit

1641

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Teraimmune Inc.

OA Round

1 (Non-Final)

This examiner grants 63% of cases after interview

— +37.0% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 945 resolved cases, 2023–2026

Examiner Intelligence

SZPERKA, MICHAEL EDWARD View full profile →

Grants 63% of resolved cases

Career Allowance Rate

592 granted / 945 resolved

+2.6% vs TC avg

Strong +37% interview lift

Without

With

+37.0%

Interview Lift

resolved cases with interview

Typical timeline

3y 0m

Avg Prosecution

41 currently pending

Career history

979

Total Applications

across all art units

Statute-Specific Performance

§101

2.7%

-37.3% vs TC avg

§103

26.7%

-13.3% vs TC avg

§102

10.8%

-29.2% vs TC avg

§112

18.6%

-21.4% vs TC avg

Black line = Tech Center average estimate • Based on career data from 945 resolved cases

Prosecution Timeline

Sep 29, 2023

Application Filed

Jun 05, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/461,697

Patent 12679882

OPTIMIZED FACTOR VIII GENE

2y 10m to grant Granted Jul 14, 2026

17/344,839

Patent 12668629

METHODS OF USING ANTI-TREM2 ANTIBODIES

5y 0m to grant Granted Jun 30, 2026

18/184,821

Patent 12653871

FACTOR IX POLYPEPTIDE FORMULATIONS

3y 3m to grant Granted Jun 16, 2026

17/843,777

Patent 12643957

Antibodies to Plasminogen Activator Inhibitor-1 (PAI-1) and Uses Thereof

3y 11m to grant Granted Jun 02, 2026

17/787,039

Patent 12637507

ANTIBODY WITH BINDING SPECIFICITY FOR HUMAN IL-13

3y 11m to grant Granted May 26, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

63%

Grant Probability

99%

With Interview (+37.0%)

3y 0m (~3m remaining)

Median Time to Grant

Low

PTA Risk

Based on 945 resolved cases by this examiner. Grant probability derived from career allowance rate.